• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to "Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!" by Stamp et al.

作者信息

Laville Solène M, Stengel Bénédicte, Massy Ziad A, Liabeuf Sophie

机构信息

CESP Centre for Research in Epidemiology and Population Health, Univ Paris-Saclay, Univ Paris Sud, UVSQ, UMRS 1018, Villejuif, France.

Nephrology Department, CHU Ambroise Pare, Boulogne, France.

出版信息

Br J Clin Pharmacol. 2019 Jun;85(6):1380-1381. doi: 10.1111/bcp.13924. Epub 2019 Apr 13.

DOI:10.1111/bcp.13924
PMID:30980562
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6533517/
Abstract
摘要

相似文献

1
Reply to "Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!" by Stamp et al.对斯坦普等人《痛风患者根据肾功能限制别嘌醇维持剂量是不合适的！》一文的回复
Br J Clin Pharmacol. 2019 Jun;85(6):1380-1381. doi: 10.1111/bcp.13924. Epub 2019 Apr 13.
2
Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!根据肾功能限制痛风患者的维持性别嘌醇剂量是不合适的！
Br J Clin Pharmacol. 2019 Jun;85(6):1378-1379. doi: 10.1111/bcp.13798. Epub 2018 Nov 12.
3
Allopurinol and kidney function: An update.别嘌醇与肾功能：最新进展
Joint Bone Spine. 2016 Jan;83(1):19-24. doi: 10.1016/j.jbspin.2015.03.013. Epub 2015 Oct 6.
4
Febuxostat for Patients With Gout and Severe Chronic Kidney Disease: Which Is the Appropriate Dosage? Comment on the Article by Saag et al.非布司他用于痛风和严重慢性肾脏病患者：合适的剂量是多少？对萨格等人文章的评论
Arthritis Rheumatol. 2016 Oct;68(10):2563-4. doi: 10.1002/art.39769.
5
Association of Chronic Kidney Disease With Allopurinol Use in Gout Treatment.慢性肾脏病与别嘌醇治疗痛风中的应用关联。
JAMA Intern Med. 2018 Nov 1;178(11):1526-1533. doi: 10.1001/jamainternmed.2018.4463.
6
Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.对于患有慢性肾病的痛风患者，可能需要更高的治疗性血浆氧嘌呤醇浓度。
J Clin Rheumatol. 2008 Feb;14(1):6-11. doi: 10.1097/RHU.0b013e318164dceb.
7
Low-Dose Allopurinol Promotes Greater Serum Urate Lowering in Gout Patients with Chronic Kidney Disease Compared with Normal Kidney Function.与肾功能正常的痛风患者相比，低剂量别嘌醇可使慢性肾脏病痛风患者的血清尿酸水平降低得更多。
Bull Hosp Jt Dis (2013). 2019 Mar;77(2):87-91.
8
Response: Renal dosing of allopurinol results in suboptimal gout care by T Neogi et al.T·尼奥吉等人的研究表明，别嘌醇的肾脏给药导致痛风治疗效果欠佳。
Ann Rheum Dis. 2017 Jan;76(1):e2. doi: 10.1136/annrheumdis-2016-210356. Epub 2016 Nov 3.
9
Allopurinol and Chronic Kidney Disease. Reply.别嘌醇与慢性肾脏病。回复。
N Engl J Med. 2020 Oct 22;383(17):1691-1692. doi: 10.1056/NEJMc2026125.
10
Relation between adverse events associated with allopurinol and renal function in patients with gout.痛风患者中别嘌醇相关不良事件与肾功能的关系。
Ann Rheum Dis. 2001 Oct;60(10):981-3. doi: 10.1136/ard.60.10.981.

本文引用的文献

1
Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!根据肾功能限制痛风患者的维持性别嘌醇剂量是不合适的！
Br J Clin Pharmacol. 2019 Jun;85(6):1378-1379. doi: 10.1111/bcp.13798. Epub 2018 Nov 12.
2
Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort.评估慢性肾脏病患者药物处方的适宜性：来自 CKD-REIN 队列的结果。
Br J Clin Pharmacol. 2018 Dec;84(12):2811-2823. doi: 10.1111/bcp.13738. Epub 2018 Sep 24.
3
Risk profile, quality of life and care of patients with moderate and advanced CKD: The French CKD-REIN Cohort Study.中重度和晚期慢性肾脏病患者的风险状况、生活质量和护理：法国 CKD-REIN 队列研究。
Nephrol Dial Transplant. 2019 Feb 1;34(2):277-286. doi: 10.1093/ndt/gfy058.
4
Severe cutaneous adverse reactions due to inappropriate medication use.因用药不当导致的严重皮肤不良反应。
Br J Dermatol. 2018 Aug;179(2):329-336. doi: 10.1111/bjd.16365. Epub 2018 May 14.
5
The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trial.肾功能对基于肌酐清除率增加别嘌醇剂量降尿酸效果和安全性的影响：一项随机对照试验的事后分析。
Arthritis Res Ther. 2017 Dec 21;19(1):283. doi: 10.1186/s13075-017-1491-x.
6
Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension study.别嘌醇剂量递增以实现血清尿酸低于 6mg/dL：一项开放标签扩展研究。
Ann Rheum Dis. 2017 Dec;76(12):2065-2070. doi: 10.1136/annrheumdis-2017-211873. Epub 2017 Aug 22.
7
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout.一项关于别嘌醇剂量递增以达到痛风患者目标血清尿酸的疗效和安全性的随机对照试验。
Ann Rheum Dis. 2017 Sep;76(9):1522-1528. doi: 10.1136/annrheumdis-2016-210872. Epub 2017 Mar 17.
8
2016 updated EULAR evidence-based recommendations for the management of gout.2016 年更新的 EULAR 痛风管理循证建议。
Ann Rheum Dis. 2017 Jan;76(1):29-42. doi: 10.1136/annrheumdis-2016-209707. Epub 2016 Jul 25.
9
Allopurinol Use and Risk of Fatal Hypersensitivity Reactions: A Nationwide Population-Based Study in Taiwan.别嘌醇的使用与致命性过敏反应风险：来自台湾的全国性基于人群的研究。
JAMA Intern Med. 2015 Sep;175(9):1550-7. doi: 10.1001/jamainternmed.2015.3536.
10
An open-label, 6-month study of allopurinol safety in gout: The LASSO study.一项别嘌醇治疗痛风安全性的开放性、6 个月研究：LASSO 研究。
Semin Arthritis Rheum. 2015 Oct;45(2):174-83. doi: 10.1016/j.semarthrit.2015.05.005. Epub 2015 May 21.